Rodman David Malcom Insider Trades & Stock Holdings

Chief Medical Officer · Mineralys Therapeutics, Inc. · Latest filing Jun 17, 2026

Rodman David Malcom, Chief Medical Officer at Mineralys Therapeutics, Inc. has 6 Form 4 trades on file since Jun 12, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($114.60K), net -$114.60K. Latest filing: disposed of 4.58K shares of $MLYS on Jun 17, 2026 at $25.

Trades on file
6
Open-market bought
$0
Open-market sold
$114.60K
Net open-market
-$114.60K
Latest filing
Jun 17, 2026

All insider trades by Rodman David Malcom

DateTicker TypeSharesPriceValue Owned afterΔOwn 1W1M6MRoleFilingStory
$MLYS Sell (Open-market sale) 10b5-1 4.58K $25 $114.60K +2.5%+7.8% Chief Medical Officer Read
$MLYS Buy (Option exercise) 4.58K $14.36 $65.82K +2.5%+7.8% Chief Medical Officer Read
$MLYS Sell (Option exercise) 6.35K $0 — +7.4%+16.8% Chief Medical Officer —
$MLYS Sell (Option exercise) 6.35K $0 — +7.4%+16.8% Chief Medical Officer —
$MLYS Buy (Option exercise) 6.35K $1.08 $6.86K +7.4%+16.8% Chief Medical Officer —
$MLYS Buy (Option exercise) 6.35K $1.08 $6.86K +7.4%+16.8% Chief Medical Officer —

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Rodman David Malcom traded

Frequently asked questions

Has Rodman David Malcom been buying or selling stock?

Rodman David Malcom has 0 open-market purchases and 1 open-market sale on file, net -$114.60K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Rodman David Malcom's latest insider trade?

disposed of 4.58K shares of $MLYS on Jun 17, 2026 at $25.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text